The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens
Open accessAbstract
The seemingly inexorable spread of antibiotic resistance genes among microbial pathogens now threatens the long-term viability of our current antimicrobial therapy to treat severe bacterial infections such as sepsis. Antibiotic resistance is reaching a crisis situation in some bacterial pathogens where few therapeutic alternatives remain and pan-resistant strains are becoming more prevalent. Non-antibiotic therapies to treat bacterial infections are now under serious consideration and one possible option is the therapeutic use of specific phage particles that target bacterial pathogens. Bacteriophage therapy has essentially been re-discovered by modern medicine after widespread use of phage therapy in the pre-antibiotic era lost favor, at least in Western countries, after the introduction of antibiotics. We review the current therapeutic rationale and clinical experience with phage therapy as a treatment for invasive bacterial infection as novel alternative to antimicrobial chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Ecology of prokaryotic viruses
Weinbauer, M. G. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2003.08.001 · Cited by 1,771
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Clinical relevance of the ESKAPE pathogens
Pendleton, J. N., Gorman, S. P., & Gilmore, B. F. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.12 · Cited by 1,423
Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge
Arias, C. A., & Murray, B. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0804651 · Cited by 1,027
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
AN INVESTIGATION ON THE NATURE OF ULTRA-MICROSCOPIC VIRUSES.
Twort, F. W. (1915) · The Lancet · doi:10.1016/s0140-6736(01)20383-3 · Cited by 901
Wright, A., Hawkins, C. H., Änggård, E. E., & Harper, D. R. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01973.x · Cited by 864
The influence of external factors on bacteriophages—review
Jończyk, E., Kłak, M., Międzybrodzki, R., & Górski, A. (2011) · Folia Microbiologica · doi:10.1007/s12223-011-0039-8 · Cited by 705
Phage Therapy in Clinical Practice: Treatment of Human Infections
Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., Kuhl, S., & Abedon, S. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725401 · Cited by 670
The Phage Proteomic Tree: a Genome-Based Taxonomy for Phage
Rohwer, F., & Edwards, R. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.16.4529-4535.2002 · Cited by 605
Human Volunteers Receiving Escherichia coli Phage T4 Orally: a Safety Test of Phage Therapy
Bruttin, A., & Brüssow, H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2874-2878.2005 · Cited by 563
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
Lu, T. K., & Collins, J. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800442106 · Cited by 529
Smith, H. W., & Huggins, M. B. (1982) · Microbiology · doi:10.1099/00221287-128-2-307 · Cited by 518
Long-circulating bacteriophage as antibacterial agents.
Merril, C. R., Biswas, B., Carlton, R., Jensen, N. C., Creed, G. J., Zullo, S., & Adhya, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3188 · Cited by 512
Merabishvili, M., Pirnay, J.-P., Verbeken, G., Chanishvili, N., Tediashvili, M., Lashkhi, N., Glonti, T., Krylov, V., Mast, J., Van Parys, L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004944 · Cited by 511
Phage as agents of lateral gene transfer
Canchaya, C., Fournous, G., Chibani-Chennoufi, S., Dillmann, M.-L., & Brüssow, H. (2003) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(03)00086-9 · Cited by 499
Summers, W. C. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.437 · Cited by 474
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial
Rhoads, D. D., Wolcott, R. D., Kuskowski, M. A., Wolcott, B. M., Ward, L. S., & Sulakvelidze, A. (2009) · Journal of Wound Care · doi:10.12968/jowc.2009.18.6.42801 · Cited by 468
Biswas, B., Adhya, S., Washart, P., Paul, B., Trostel, A. N., Powell, B., Carlton, R., & Merril, C. R. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.204-210.2002 · Cited by 467
Smith, H. W., & Huggins, M. B. (1983) · Microbiology · doi:10.1099/00221287-129-8-2659 · Cited by 436
Phage Therapy—History from Twort and d'Herelle Through Soviet Experience to Current Approaches
Chanishvili, N. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00001-3 · Cited by 407
Bacteriophages: an appraisal of their role in the treatment of bacterial infections
Hanlon, G. W. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.04.006 · Cited by 376
Clinical Aspects of Phage Therapy
Międzybrodzki, R., Borysowski, J., Weber-Dąbrowska, B., Fortuna, W., Letkiewicz, S., Szufnarowski, K., Pawełczyk, Z., Rogóż, P., Kłak, M., Wojtasik, E., et al. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00003-7 · Cited by 373
Hatfull, G. F. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.09.004 · Cited by 371
Freire-Moran, L., Aronsson, B., Manz, C., Gyssens, I. C., So, A. D., Monnet, D. L., & Cars, O. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.02.003 · Cited by 335
Bacteriophages show promise as antimicrobial agents
Alisky, J., Iczkowski, K., Rapoport, A., & Troitsky, N. (1998) · Journal of Infection · doi:10.1016/s0163-4453(98)92874-2 · Cited by 318
Bacteriophages and their implications on future biotechnology: a review
Haq, I. U., Chaudhry, W. N., Akhtar, M. N., Andleeb, S., & Qadri, I. (2012) · Virology Journal · doi:10.1186/1743-422x-9-9 · Cited by 304
Bacteriophages Can Treat and Prevent Pseudomonas aeruginosa Lung Infections
Debarbieux, L., Leduc, D., Maura, D., Morello, E., Criscuolo, A., Grossi, O., Balloy, V., & Touqui, L. (2010) · The Journal of Infectious Diseases · doi:10.1086/651135 · Cited by 304
The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?
Pirnay, J.-P., De Vos, D., Verbeken, G., Merabishvili, M., Chanishvili, N., Vaneechoutte, M., Zizi, M., Laire, G., Lavigne, R., Huys, I., et al. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0313-5 · Cited by 298
Barrow, P., Lovell, M., & Berchieri, A. (1998) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.5.3.294-298.1998 · Cited by 293
The Use of Phages for the Removal of Infectious Biofilms
Azeredo, J., & Sutherland, I. (2008) · Current Pharmaceutical Biotechnology · doi:10.2174/138920108785161604 · Cited by 292
Reverse Transcriptase-Mediated Tropism Switching in Bordetella Bacteriophage
Liu, M., Deora, R., Doulatov, S. R., Gingery, M., Eiserling, F. A., Preston, A., Maskell, D. J., Simons, R. W., Cotter, P. A., Parkhill, J., et al. (2002) · Science · doi:10.1126/science.1067467 · Cited by 288
Morello, E., Saussereau, E., Maura, D., Huerre, M., Touqui, L., & Debarbieux, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016963 · Cited by 275
Phage as a Modulator of Immune Responses
Górski, A., Międzybrodzki, R., Borysowski, J., Dąbrowska, K., Wierzbicki, P., Ohams, M., Korczak-Kowalska, G., Olszowska-Zaremba, N., Łusiak-Szelachowska, M., Kłak, M., et al. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00002-5 · Cited by 266
Prokaryote viruses studied by electron microscopy
Ackermann, H.-W., & Prangishvili, D. (2012) · Archives of Virology · doi:10.1007/s00705-012-1383-y · Cited by 262
Drulis-Kawa, Z., Majkowska-Skrobek, G., Maciejewska, B., Delattre, A.-S., & Lavigne, R. (2012) · Current Protein & Peptide Science · doi:10.2174/138920312804871193 · Cited by 261
Matsuzaki, S., Yasuda, M., Nishikawa, H., Kuroda, M., Ujihara, T., Shuin, T., Shen, Y., Jin, Z., Fujimoto, S., Nasimuzzaman, M. D., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/374001 · Cited by 260
Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh
Sarker, S. A., McCallin, S., Barretto, C., Berger, B., Pittet, A.-C., Sultana, S., Krause, L., Huq, S., Bibiloni, R., Bruttin, A., et al. (2012) · Virology · doi:10.1016/j.virol.2012.09.002 · Cited by 240
Bacteriophage penetration in vertebrates
Dabrowska, K., Switala-Jelen, K., Opolski, A., Weber-Dabrowska, B., & Gorski, A. (2005) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2004.02422.x · Cited by 240
Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Kutter, E., Sarker, S., & Brüssow, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2558-2569.2004 · Cited by 234
Alemayehu, D., Casey, P. G., McAuliffe, O., Guinane, C. M., Martin, J. G., Shanahan, F., Coffey, A., Ross, R. P., & Hill, C. (2012) · mBio · doi:10.1128/mbio.00029-12 · Cited by 231
Treatment of experimental infections of mice with bacteriophages
SOOTHILL, J. S. (1992) · Journal of Medical Microbiology · doi:10.1099/00222615-37-4-258 · Cited by 220
Reversing Bacterial Resistance to Antibiotics by Phage-Mediated Delivery of Dominant Sensitive Genes
Edgar, R., Friedman, N., Molshanski-Mor, S., & Qimron, U. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.05741-11 · Cited by 217
Further Investigations on the Nature of Ultra-Microscopic Viruses and their Cultivation
Twort, F. W. (1936) · Journal of Hygiene · doi:10.1017/s0022172400043606 · Cited by 210
Watanabe, R., Matsumoto, T., Sano, G., Ishii, Y., Tateda, K., Sumiyama, Y., Uchiyama, J., Sakurai, S., Matsuzaki, S., Imai, S., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00635-06 · Cited by 206
Bacteriophages as biocontrol agents of food pathogens
Mahony, J., McAuliffe, O., Ross, R. P., & van Sinderen, D. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.10.008 · Cited by 203
The Staphylococci Phages Family: An Overview
Deghorain, M., & Van Melderen, L. (2012) · Viruses · doi:10.3390/v4123316 · Cited by 202
Variation Due to Change in the Individual Gene
Muller, H. J. (1922) · The American Naturalist · doi:10.1086/279846 · Cited by 201
Experimental Bacteriophage Protection against Staphylococcus aureus Abscesses in a Rabbit Model
Wills, Q. F., Kerrigan, C., & Soothill, J. S. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1220-1221.2005 · Cited by 180
Bacteriophage Therapy in Implant-Related Infections: An Experimental Study
Yilmaz, C., Colak, M., Yilmaz, B. C., Ersoz, G., Kutateladze, M., & Gozlugol, M. (2013) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/jbjs.k.01135 · Cited by 174
Bacteriophage Therapy in Humans
Sulakvelidze, A., & Kutter, E. (2004) · Bacteriophages · doi:10.1201/9780203491751.ch14 · Cited by 170
Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition
Morales, E., Cots, F., Sala, M., Comas, M., Belvis, F., Riu, M., Salvadó, M., Grau, S., Horcajada, J. P., Montero, M. M., et al. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-122 · Cited by 169
Goodridge, L. D. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725348 · Cited by 155
Hung, C., Kuo, C.-F., Wang, C.-H., Wu, C.-M., & Tsao, N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01123-10 · Cited by 153
Kumari, S., Harjai, K., & Chhibber, S. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.018580-0 · Cited by 149
Pouillot, F., Chomton, M., Blois, H., Courroux, C., Noelig, J., Bidet, P., Bingen, É., & Bonacorsi, S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06330-11 · Cited by 145
Eaton, M. D., & Bayne‐Jones, S. (1934) · JAMA · doi:10.1001/jama.1934.72750490003007 · Cited by 138
Evolution of Foodborne Pathogens via Temperate Bacteriophage-Mediated Gene Transfer
Brabban, A. D., Hite, E., & Callaway, T. R. (2005) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2005.2.287 · Cited by 131
Bacteriophage therapy for the treatment of infections.
Górski, A., Międzybrodzki, R., Borysowski, J., et al. (2009) · PubMed · Cited by 129
Wang, J., Hu, B., Xu, M., Yan, Q., Liu, S., Zhu, X., Sun, Z., Reed, E., Ding, L., Gong, J., et al. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.2.309 · Cited by 121
Interaction of Bacteriophage l with Its E. coli Receptor, LamB
Chatterjee, S., & Rothenberg, E. (2012) · Viruses · doi:10.3390/v4113162 · Cited by 120
Role of Staphylococcal Phage and SaPI Integrase in Intra- and Interspecies SaPI Transfer
Maiques, E., Úbeda, C., Tormo‐Más, M. Á., Ferrer, M. D., Lasa, Í., Novick, R. P., & Penadés, J. R. (2007) · Journal of Bacteriology · doi:10.1128/jb.00619-07 · Cited by 115
Evidence that TraT interacts with OmpA of Escherichia coli
Riede, I., & Eschbach, M.-L. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)80905-x · Cited by 101
Ceyssens, P., & Lavigne, R. (2010) · Future Microbiology · doi:10.2217/fmb.10.66 · Cited by 99
The antibiotic R&D pipeline: an update
Jabes, D. L. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.08.002 · Cited by 96
O’Shea, Y. A., & Boyd, E. F. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11339.x · Cited by 83
Jain, P., Hartman, T. E., Eisenberg, N., O’Donnell, M. R., Kriakov, J., Govender, K., Makume, M. T., Thaler, D. S., Hatfull, G. F., Sturm, A. W., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06192-11 · Cited by 82
Wang, J., Hu, B., Xu, M., Yan, Q., Liu, S., Zhu, X., Sun, Z., Tao, D., Ding, L., Reed, E., et al. (2006) · PubMed · Cited by 81
Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice
Sunagar, R., Patil, S. A., & Chandrakanth, R. K. (2010) · Research in Microbiology · doi:10.1016/j.resmic.2010.09.011 · Cited by 69
Międzybrodzki, R., Fortuna, W., Weber‐Dąbrowska, B., & Górski, A. (2009) · Clinical and Experimental Medicine · doi:10.1007/s10238-009-0044-2 · Cited by 67
Weber‐Dąbrowska, B., Zimecki, M., & Mulczyk, M. (2000) · PubMed · Cited by 65
Merabishvili, M., Vos, D. D., Verbeken, G., Kropinski, A. M., Vandenheuvel, D., Lavigne, R., Wattiau, P., Mast, J., Ragimbeau, C., Mossong, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052709 · Cited by 59
Curated list of prokaryote viruses with fully sequenced genomes
Ackermann, H., & Kropinski, A. M. (2007) · Research in Microbiology · doi:10.1016/j.resmic.2007.07.006 · Cited by 48
Phage therapy of Cronobacter-induced urinary tract infection in mice
Tóthová, Ľ., Celec, P., Bábíčková, J., Gajdosova, J., Al-Alami, H., Kamodyová, N., Drahovská, H., Liptáková, A., Turňa, J., & Hodosy, J. (2011) · Medical Science Monitor · doi:10.12659/msm.881844 · Cited by 47
Eaton, M. D., & Bayne‐Jones, S. (1934) · JAMA · doi:10.1001/jama.1934.72750500003009 · Cited by 33
Aiello, A. E., King, N. B., & Foxman, B. (2006) · American Journal of Public Health · doi:10.2105/ajph.2005.077214 · Cited by 30
2004 ASM Conference on the New Phage Biology: the ‘Phage Summit’
Adhya, S. L., Black, L. W., Friedman, D. I., Hatfull, G. F., Kreuzer, K. N., Merril, C. R., Oppenheim, A. B., Rohwer, F. L., & Young, R. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04509.x · Cited by 7
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Hypervirulent Klebsiella pneumoniae
Russo, T. A., & Marr, C. M. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-19 · Cited by 1,311
Antibiotic alternatives: the substitution of antibiotics in animal husbandry?
Cheng, G., Hao, H., Xie, S., Wang, X., Dai, M., Huang, L., & Yuan, Z. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00217 · Cited by 622
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Malik, D. J., Sokolov, I. J., Vinner, G. K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G. T., Clokie, M. R. J., Garton, N. J., Stapley, A. G. F., & Kirpichnikova, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.014 · Cited by 594
Metadata
- Authors
- Wittebole, X., De Roock, S., & Opal, S. M.
- Venue
- Virulence
- Publisher
- Informa UK Limited
- Published
- 2013-08-13
- Volume
- 5
- Issue
- 1
- Pages
- 226-235
- ISSN
- 2150-5594 (ISSN-L)
- 2150-5608
- OpenAlex
- W1974394752
- Cited by
- 599
- References
- 78
- FWCI
- 17.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.